Affimed Announces First Patient Successfully Dosed in the First-in-Human Study of AFM28 for the Treatment of Patients with Relapsed / Refractory CD123-Positive Acute Myeloid Leukemia
March 29, 2023
March 29, 2023
March 23, 2023
March 16, 2023
March 14, 2023
February 22, 2023
February 8, 2023
January 9, 2023
December 22, 2022
December 12, 2022
December 10, 2022